Apellis Pharmaceuticals buy BiotechBee
Start price
17.09.23
/
60%
€41.00
Target price
30.09.25
€60.00
Performance (%)
-37.09%
Price
13:32
€25.80
Summary
This prediction is currently active. Massive losses of -37.09% have been the result for the BUY prediction by BiotechBee. This prediction currently runs until 30.09.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Apellis Pharmaceuticals | - | - | - |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
According to BiotechBee what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Buy mit Kursziel 60,0
Stopped prediction by BiotechBee for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.00
30.07.23
30.07.23
€50.00
31.01.26
31.01.26
10.81%
17.09.23
17.09.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
17.07.23
17.07.23
€90.00
31.03.26
31.03.26
18.81%
17.07.23
17.07.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€69.48
29.09.22
29.09.22
€80.00
31.12.24
31.12.24
17.30%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€64.19
07.09.22
07.09.22
€35.00
31.12.24
31.12.24
8.24%
29.09.22
29.09.22
Could be very worthwhile Investment >20% year